Your browser doesn't support javascript.
loading
Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein.
Krishna, B A; Spiess, K; Poole, E L; Lau, B; Voigt, S; Kledal, T N; Rosenkilde, M M; Sinclair, J H.
Affiliation
  • Krishna BA; Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge CB20QQ, UK.
  • Spiess K; Laboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen DK-2200, Denmark.
  • Poole EL; Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge CB20QQ, UK.
  • Lau B; Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge CB20QQ, UK.
  • Voigt S; Department of Infectious Diseases, Robert Koch Institute, Nordufer 20, Berlin 13353, Germany.
  • Kledal TN; Department of Pediatric Oncology/Hematology/SCT, Charité-Universitätsmedizin, Berlin 13353, Germany.
  • Rosenkilde MM; Section for Virology, The National Veterinary Institute, Technical University of Denmark, Frederiksberg DK-1870, Denmark.
  • Sinclair JH; Laboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen DK-2200, Denmark.
Nat Commun ; 8: 14321, 2017 02 02.
Article in En | MEDLINE | ID: mdl-28148951
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Proteins / Recombinant Fusion Proteins / Virus Latency / Receptors, Chemokine / Cytomegalovirus Limits: Humans Language: En Journal: Nat Commun Year: 2017 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Proteins / Recombinant Fusion Proteins / Virus Latency / Receptors, Chemokine / Cytomegalovirus Limits: Humans Language: En Journal: Nat Commun Year: 2017 Document type: Article